Expert Witness and Lawmakers Highlight Root Cause of High Rx Prices: Big Pharma’s Anti-Competitive Tactics
Hearing Confirms Big Drug Companies Would Benefit from Misguided Proposals Targeting Pharmacy Benefits This week, the U.S. House Committee on Oversight and Accountability held a hearing where lawmakers and an expert witness, Frederick Isasi, JD, MPH, executive director of Families